Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study

Abstract Objectives Describe patterns of pharmacotherapy and psychological treatment and evaluate receipt of minimally adequate treatment for incident depression and anxiety in individuals with inflammatory arthritis (IA). Methods We used population-based linked administrative health databases from...

Full description

Saved in:
Bibliographic Details
Main Authors: Alyssa Howren, Eric C. Sayre, J. Antonio Avina-Zubieta, Joseph H. Puyat, Deborah Da Costa, Hui Xie, Eileen Davidson, Amit Gupta, Mary A. De Vera
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-024-03466-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585510451675136
author Alyssa Howren
Eric C. Sayre
J. Antonio Avina-Zubieta
Joseph H. Puyat
Deborah Da Costa
Hui Xie
Eileen Davidson
Amit Gupta
Mary A. De Vera
author_facet Alyssa Howren
Eric C. Sayre
J. Antonio Avina-Zubieta
Joseph H. Puyat
Deborah Da Costa
Hui Xie
Eileen Davidson
Amit Gupta
Mary A. De Vera
author_sort Alyssa Howren
collection DOAJ
description Abstract Objectives Describe patterns of pharmacotherapy and psychological treatment and evaluate receipt of minimally adequate treatment for incident depression and anxiety in individuals with inflammatory arthritis (IA). Methods We used population-based linked administrative health databases from British Columbia, Canada to evaluate pharmacotherapy and psychological treatments for incident depression and/or anxiety among individuals with IA and without IA (‘IA-free controls’). We defined minimally adequate pharmacotherapy as antidepressant prescriptions filled with ≥ 84 days’ supply and adequate psychological treatment as ≥ 4 counselling/psychotherapy services. Multivariable logistic regression models were used to evaluate the odds of individuals with IA receiving minimally adequate pharmacotherapy and/or psychological treatment compared to IA-free controls. Results 6,951 (mean age 54.8 ± 18.3 years; 65.5% female) individuals with IA had incident depression and 3,701 (mean age 52.9 ± 16.8 years; 74.3% female) had incident anxiety. Minimally adequate pharmacotherapy and psychological treatment for depression was respectively observed in 50.5% and 19.6% of those with IA, proportions similar to IA-free controls (pharmacotherapy: aOR 1.10, 95% CI 1.00 to 1.21; psychological: aOR 1.07, 95% CI 0.94 to 1.21). Results were similar regarding anxiety treatment. Individuals with IA had a significantly greater likelihood of dispensing ≥ 1 benzodiazepine (anxiety: IA 45.0%, IA-free controls 39.0%, p-value < 0.001) and ≥ 1 tricyclic antidepressant prescription (anxiety: IA 12.8%, IA-free controls 7.8%, p-value < 0.001). Significantly higher average days’ supply of benzodiazepines was observed for IA (anxiety: IA 123.7 days, controls 112.4 days, p-value = 0.003). Conclusions A substantial proportion of individuals with IA were not receiving adequate mental health treatment for depression and anxiety, a finding similar for IA-free controls. The undertreatment of mental disorders for people with IA has well-known negative implications for the provision of effective rheumatology care. It remains fundamental to expand publicly funded health care to include mental health services in an effort to address unmet counselling needs.
format Article
id doaj-art-99a3016614dd47f7b87100ec4a31fef0
institution Kabale University
issn 1478-6362
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj-art-99a3016614dd47f7b87100ec4a31fef02025-01-26T12:46:06ZengBMCArthritis Research & Therapy1478-63622025-01-0127111010.1186/s13075-024-03466-8Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based studyAlyssa Howren0Eric C. Sayre1J. Antonio Avina-Zubieta2Joseph H. Puyat3Deborah Da Costa4Hui Xie5Eileen Davidson6Amit Gupta7Mary A. De Vera8Faculty of Pharmaceutical Sciences, University of British ColumbiaBritish Columbia Centre on Substance UseArthritis Research CanadaCentre for Advancing Health OutcomesArthritis Research CanadaArthritis Research CanadaArthritis Research CanadaFaculty of Pharmaceutical Sciences, University of British ColumbiaFaculty of Pharmaceutical Sciences, University of British ColumbiaAbstract Objectives Describe patterns of pharmacotherapy and psychological treatment and evaluate receipt of minimally adequate treatment for incident depression and anxiety in individuals with inflammatory arthritis (IA). Methods We used population-based linked administrative health databases from British Columbia, Canada to evaluate pharmacotherapy and psychological treatments for incident depression and/or anxiety among individuals with IA and without IA (‘IA-free controls’). We defined minimally adequate pharmacotherapy as antidepressant prescriptions filled with ≥ 84 days’ supply and adequate psychological treatment as ≥ 4 counselling/psychotherapy services. Multivariable logistic regression models were used to evaluate the odds of individuals with IA receiving minimally adequate pharmacotherapy and/or psychological treatment compared to IA-free controls. Results 6,951 (mean age 54.8 ± 18.3 years; 65.5% female) individuals with IA had incident depression and 3,701 (mean age 52.9 ± 16.8 years; 74.3% female) had incident anxiety. Minimally adequate pharmacotherapy and psychological treatment for depression was respectively observed in 50.5% and 19.6% of those with IA, proportions similar to IA-free controls (pharmacotherapy: aOR 1.10, 95% CI 1.00 to 1.21; psychological: aOR 1.07, 95% CI 0.94 to 1.21). Results were similar regarding anxiety treatment. Individuals with IA had a significantly greater likelihood of dispensing ≥ 1 benzodiazepine (anxiety: IA 45.0%, IA-free controls 39.0%, p-value < 0.001) and ≥ 1 tricyclic antidepressant prescription (anxiety: IA 12.8%, IA-free controls 7.8%, p-value < 0.001). Significantly higher average days’ supply of benzodiazepines was observed for IA (anxiety: IA 123.7 days, controls 112.4 days, p-value = 0.003). Conclusions A substantial proportion of individuals with IA were not receiving adequate mental health treatment for depression and anxiety, a finding similar for IA-free controls. The undertreatment of mental disorders for people with IA has well-known negative implications for the provision of effective rheumatology care. It remains fundamental to expand publicly funded health care to include mental health services in an effort to address unmet counselling needs.https://doi.org/10.1186/s13075-024-03466-8Rheumatoid arthritisPsoriatic arthritisAnkylosing spondylitisDepressionAnxiety
spellingShingle Alyssa Howren
Eric C. Sayre
J. Antonio Avina-Zubieta
Joseph H. Puyat
Deborah Da Costa
Hui Xie
Eileen Davidson
Amit Gupta
Mary A. De Vera
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
Arthritis Research & Therapy
Rheumatoid arthritis
Psoriatic arthritis
Ankylosing spondylitis
Depression
Anxiety
title Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
title_full Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
title_fullStr Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
title_full_unstemmed Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
title_short Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
title_sort do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety a population based study
topic Rheumatoid arthritis
Psoriatic arthritis
Ankylosing spondylitis
Depression
Anxiety
url https://doi.org/10.1186/s13075-024-03466-8
work_keys_str_mv AT alyssahowren doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT ericcsayre doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT jantonioavinazubieta doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT josephhpuyat doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT deborahdacosta doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT huixie doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT eileendavidson doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT amitgupta doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy
AT maryadevera doindividualswithinflammatoryarthritisreceiveminimallyadequatetreatmentforincidentdepressionandanxietyapopulationbasedstudy